Giant Biogene Holding Co (HKSE:02367) Revenue : HK$3,855 Mil (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Giant Biogene Holding Co Revenue?

Giant Biogene Holding Co's revenue for the six months ended in Dec. 2023 was HK$2,098 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$3,855 Mil. Giant Biogene Holding Co's Revenue per Share for the six months ended in Dec. 2023 was HK$2.19. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$3.93.

During the past 12 months, the average Revenue per Share Growth Rate of Giant Biogene Holding Co was 51.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 40.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 5 years, Giant Biogene Holding Co's highest 3-Year average Revenue per Share Growth Rate was 40.20% per year. The lowest was 34.00% per year. And the median was 37.10% per year.

Giant Biogene Holding Co Revenue Historical Data

The historical data trend for Giant Biogene Holding Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Giant Biogene Holding Co Revenue Chart

Giant Biogene Holding Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Revenue

1,064.57

1,411.23

1,900.97

2,640.41

3,854.63

Giant Biogene Holding Co Semi-Annual Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Revenue	Get a 7-Day Free Trial			-	1,154.49	1,540.57	1,756.28	2,098.36

Competitive Comparison of Giant Biogene Holding Co's Revenue

For the Household & Personal Products subindustry, Giant Biogene Holding Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Giant Biogene Holding Co's Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Giant Biogene Holding Co's Revenue distribution charts can be found below:

* The bar in red indicates where Giant Biogene Holding Co's Revenue falls into.

Giant Biogene Holding Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$3,855 Mil.

Giant Biogene Holding Co (HKSE:02367) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Giant Biogene Holding Co Revenue Related Terms

Thank you for viewing the detailed overview of Giant Biogene Holding Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Giant Biogene Holding Co (HKSE:02367) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Giant Biogene Holding Co Ltd (HKSE:02367) » Definitions » Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1855, Shanglin Yuan 7th Road, Chang’an District, Shaanxi Province, Xi’an, CHN

Website

http://www.xajuzi.com

Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty and health properties such as skin repair, anti-aging, whitening, moisturizing and immunity improvement with a broad range of applications in the beauty and health sectors.

Giant Biogene Holding Co (HKSE:02367) Headlines

No Headlines